Biotoxtech Co. Ltd Asset Resilience Ratio

Latest as of March 2026: 7.69%

Biotoxtech Co. Ltd asset resilience ratio. Biotoxtech Co. Ltd (086040) has an Asset Resilience Ratio of 7.69% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 086040 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩10.00 Billion

≈ $6.78 Million USD Cash + Short-term Investments

Total Assets

₩130.06 Billion

≈ $88.14 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Biotoxtech Co. Ltd (2011–2025)

Asset resilience ratio of Biotoxtech Co. Ltd from 2011 to 2025. This chart shows how Biotoxtech Co. Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Biotoxtech Co. Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Biotoxtech Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 086040 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.00 Billion	7.69%
Total Liquid Assets	₩10.00 Billion	7.69%

Asset Resilience Insights

Limited Liquidity: Biotoxtech Co. Ltd maintains only 7.69% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Biotoxtech Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Biotoxtech Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pluristem TA:PSTI	Biotechnology & Medical Research	48.26%
Hadasit Bio TA:HDST	Biotechnology & Medical Research	57.00%
Purple Biotech Ltd TA:KTOV	Biotechnology & Medical Research	0.01%
Peptron Inc KQ:087010	Biotechnology & Medical Research	37.11%
Bioneer Corporation KQ:064550	Biotechnology & Medical Research	14.92%
MEDIPOST Co. Ltd KQ:078160	Biotechnology & Medical Research	0.72%
Cell Biotech Co. Ltd KQ:049960	Biotechnology & Medical Research	54.84%
Macrogen Inc KQ:038290	Biotechnology & Medical Research	3.56%

Biotoxtech Co. Ltd Asset Resilience Ratio by Year (2011–2025)

Biotoxtech Co. Ltd asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Biotoxtech Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.22%	₩9.50 Billion ≈ $6.44 Million	₩131.61 Billion ≈ $89.19 Million	-7.75pp
2024-12-31	14.97%	₩20.38 Billion ≈ $13.81 Million	₩136.19 Billion ≈ $92.29 Million	-12.94pp
2023-12-31	27.91%	₩41.04 Billion ≈ $27.81 Million	₩147.04 Billion ≈ $99.64 Million	+5.47pp
2022-12-31	22.44%	₩28.21 Billion ≈ $19.12 Million	₩125.70 Billion ≈ $85.19 Million	-7.96pp
2021-12-31	30.41%	₩27.59 Billion ≈ $18.70 Million	₩90.74 Billion ≈ $61.49 Million	-1.97pp
2020-12-31	32.38%	₩20.61 Billion ≈ $13.97 Million	₩63.65 Billion ≈ $43.14 Million	+16.81pp
2019-12-31	15.57%	₩9.37 Billion ≈ $6.35 Million	₩60.18 Billion ≈ $40.78 Million	-1.80pp
2018-12-31	17.37%	₩10.97 Billion ≈ $7.43 Million	₩63.14 Billion ≈ $42.79 Million	+3.81pp
2017-12-31	13.56%	₩8.10 Billion ≈ $5.49 Million	₩59.77 Billion ≈ $40.51 Million	-11.14pp
2016-12-31	24.70%	₩11.86 Billion ≈ $8.04 Million	₩48.01 Billion ≈ $32.53 Million	+17.97pp
2015-12-31	6.72%	₩3.05 Billion ≈ $2.07 Million	₩45.38 Billion ≈ $30.75 Million	-4.62pp
2014-12-31	11.34%	₩5.43 Billion ≈ $3.68 Million	₩47.84 Billion ≈ $32.42 Million	+4.65pp
2013-12-31	6.70%	₩3.10 Billion ≈ $2.10 Million	₩46.29 Billion ≈ $31.37 Million	-1.14pp
2012-12-31	7.83%	₩3.50 Billion ≈ $2.37 Million	₩44.68 Billion ≈ $30.28 Million	-1.31pp
2011-12-31	9.14%	₩4.04 Billion ≈ $2.74 Million	₩44.19 Billion ≈ $29.95 Million	--

pp = percentage points

About Biotoxtech Co. Ltd

KQ:086040 Korea Biotechnology & Medical Research

Market Cap

$20.91 Million

₩30.86 Billion KRW

Market Cap Rank

#24796 Global

#1798 in Korea

Share Price

₩2120.00

Change (1 day)

+2.17%

52-Week Range

₩1983.00 - ₩3925.00

All Time High

₩23000.00